Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Orthopediatrics (KIDS) EPS (Weighted Average and Diluted) (2019 - 2026)

Orthopediatrics has reported EPS (Weighted Average and Diluted) over the past 8 years, most recently at -$0.45 for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) rose 2.17% year-over-year to -$0.45; the TTM value through Mar 2026 reached -$1.68, up 4.55%, while the annual FY2025 figure was -$1.69, 3.05% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 was -$0.45 at Orthopediatrics, down from -$0.43 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.87 in Q3 2022 and troughed at -$0.7 in Q4 2024.
  • A 5-year average of -$0.28 and a median of -$0.34 in 2024 define the central range for EPS (Weighted Average and Diluted).
  • On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 890.91% in 2022 and fell as far as 10001.74% in 2022.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.37 in 2022, then rose by 21.62% to -$0.29 in 2023, then plummeted by 141.38% to -$0.7 in 2024, then skyrocketed by 38.57% to -$0.43 in 2025, then dropped by 4.65% to -$0.45 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for KIDS at -$0.45 in Q1 2026, -$0.43 in Q4 2025, and -$0.5 in Q3 2025.